Table of Contents Table of Contents
Previous Page  5 / 9 Next Page
Information
Show Menu
Previous Page 5 / 9 Next Page
Page Background

Volume 6

Journal of Infectious Diseases & Therapy

ISSN: 2332-0877

Infection Prevention 2018

December 06-07, 2018

Page 43

Notes:

conference

series

.com

December 06-07, 2018 | Valencia, Spain

14

th

World Congress on

Infection Prevention and Control

Sharad Kumar Yadav, J Infect Dis Ther 2018, Volume 6

DOI: 10.4172/2332-0877-C6-052

Recent advances in phage display technology

E

mergence of prokaryotic and eukaryotic expression system for the use of antibody production in the beginning years of 1980s was

a surprise entry for the new era of ‘IMMUNOTECHNOLOGY’ [a branch of biotechnology that employs sets to bio-technique for

the production of immunobiologicals]. Entry of phage display system during the years of 1990s for the antibody fragment expression

has been created a bigger achievement and turned into a milestone, which concludes the method of phage display technology for the

production of small fragments of antibodies that must possess the quality and the characteristic of binding to the antigens specifically

which are popularly and most commonly known as Nanobodies. Phage display technology is a simpler, less time consuming and

more efficient approach than the conventional methodology of the antibody production, which contains a number of component

for the production of small fragment specific antibodies that includes the target or the antigen in anticipation to the ligand or binder

or the antibody which are meant to be produced, next to this it concludes a Phage Display Library, A Phage system, Appropriate

Selection or screening process, Appropriate Expression and purification system. The most common bacteriophages used are M13,

and FD filamentous phage, though T4, T7 and λ Phage have also been used in some cases.

Biography

Sharad Kumar Yadav has 28 years of teaching and research experience and has served to various senior positions of the University including Registrar of the DUVASU

University. He is currently Professor, Head of Department of Veterinary Microbiology, and Director at Cow Research Institute at DUVASU, Mathura India. He has published

number of papers in reputed International & National journals and has a vast experience in the arena of BHV-I virus.

sharadyadav944@gmail.com

Sharad Kumar Yadav

Veterinary University, India